«

»

Sep 20

A real–world comparison of clopidogrel vs. prasugrel in about 12000 acute coronary syndrome (ACS)

A real–world comparison of clopidogrel vs. prasugrel in about 12000 acute coronary syndrome (ACS) patients undergoing PCI revealed no significant differences in the rate of major adverse cardiovascular events (MACE) between the two antiplatelet agents, suggested a new study presented at the TCT 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>